Humana Inc vs Quantum Computing Inc — how do they compare? Humana Inc trades at $443 (market cap $46.49B), while Quantum Computing Inc trades at $7.58 (market cap $1.69B). The key difference: Humana Inc is far larger — about 27.5× Quantum Computing Inc's market cap, and Humana Inc pays a 0.91% dividend while Quantum Computing Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Quantum Computing Inc for 25 Days on average.
| HUM | QUBT | |
|---|---|---|
Market Cap | $46.49B | $1.69B |
Volume | 2,567,704 | 7,991,522 |
Sector | Health | Technology |
52-Week High | $409.85 | $21.78 |
52-Week Low | $163.67 | $6.31 |
Typical Hold Time | 53 Days | 25 Days |
Enterprise Value | $53.84B | $753.24M |
Dividend Yield | 0.91% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $396.51, down 1.92% on the day, with strong technical momentum showing bullish moving averages and key support at $391. The company demonstrates consistent revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent quarterly earnings have exceeded expectations, with Q2 2026 EPS of $7.61 beating estimates of $7.27. Analyst sentiment remains positive with a $432.63 consensus price target representing 9% upside potential from current levels.
The investment case centers on Humana's dominant Medicare Advantage position and consistent revenue growth, though margin pressure and regulatory scrutiny present headwinds. With 43% of analysts maintaining buy ratings and institutional accumulation continuing, the stock offers exposure to healthcare demographics but requires monitoring of enrollment trends and cost management execution.
Quantum Computing Inc. (QUBT) trades at $7.62, down 3.05% today, with a bearish technical signal despite bullish oscillators. The company shows explosive revenue growth from $682K in 2025 to $10M in 2026 but remains deeply unprofitable with a -152.45% net income margin. Recent developments include the Dirac-3S quantum system announcement and a $42.5M backlog, though rising expenses and cash burn persist.
Analysts maintain a bullish consensus with a $17.33 price target (75% buy ratings), seeing potential in QUBT's quantum technology expansion. However, significant execution risks, continued losses, and high valuation (P/S 157.36) create substantial downside potential if commercialization timelines slip or funding needs increase.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →